ADC Therapeutics SA Ownership 2024 | Who Owns ADC Therapeutics SA Now?
Institutional Ownership
61.75%
Insider Ownership
20.96%
Retail Ownership
17.29%
Institutional Holders
71.00
ADC Therapeutics SA Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| REDMILE GROUP, LLC | 18.50% | 2.92% | 15,269,217 | - | - | 48,250,726 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 11.59% | 9.04% | 9,570,000 | 2,519,700 | 35.74% | 30,241,200 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 5.23% | 0.27% | 4,316,824 | 4,316,824 | 100.00% | 13,641,164 | Jun 30, 2024 |
| BLACKROCK INC. | 4.31% | 0.00% | 3,554,742 | 3,554,742 | 100.00% | 11,232,984 | Jun 30, 2024 |
| MORGAN STANLEY | 3.59% | 0.00% | 2,965,229 | 244,834 | 9.00% | 9,370,123 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.14% | 1.32% | 1,768,770 | 1,267,548 | 252.89% | 5,589,313 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.85% | 0.00% | 1,524,717 | -15,792 | -1.03% | 4,818,106 | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1.57% | 0.17% | 1,296,153 | 1,296,153 | 100.00% | 4,095,843 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.47% | 0.00% | 1,216,418 | 22,571 | 1.89% | 3,843,881 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.23% | 0.08% | 1,018,461 | 1,018,461 | 100.00% | 3,218,337 | Jun 30, 2024 |
| STATE STREET CORP | 1.20% | 0.00% | 991,296 | 991,296 | 100.00% | 3,132,495,000 | Jun 30, 2024 |
| VANTAGE CONSULTING GROUP INC | 1.03% | 2.00% | 850,737 | - | - | 2,688,328 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.00% | 0.00% | 824,717 | 824,717 | 100.00% | 2,606,104 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.99% | 0.00% | 816,456 | -193,981 | -19.20% | 2,580,001 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 0.89% | 0.64% | 733,568 | - | - | 2,318,075 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.83% | 0.30% | 685,547 | 685,547 | 100.00% | 2,166,329 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.58% | 0.17% | 474,744 | 474,744 | 100.00% | 1,500,191 | Jun 30, 2024 |
| GCM GROSVENOR HOLDINGS, LLC | 0.50% | 0.19% | 410,888 | - | - | 1,298,406 | Jun 30, 2024 |
| VANGUARD GROUP INC | 0.49% | - | 404,229 | 404,229 | 100.00% | 1,277,364 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.40% | 0.00% | 328,764 | 273,851 | 498.70% | 1,038,894 | Jun 30, 2024 |
ADC Therapeutics SA's largest institutional shareholder is REDMILE GROUP, LLC, holding 18.50% of the company's total share outstanding, currently valued at $48.25M. The top 10 institutional shareholders own together 51.48% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PROSIGHT MANAGEMENT, LP | 11.59% | 9.04% | 9,570,000 | 2,519,700 | 35.74% | 30,241,200 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 18.50% | 2.92% | 15,269,217 | - | - | 48,250,726 | Jun 30, 2024 |
| VANTAGE CONSULTING GROUP INC | 1.03% | 2.00% | 850,737 | - | - | 2,688,328 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.14% | 1.32% | 1,768,770 | 1,267,548 | 252.89% | 5,589,313 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 0.89% | 0.64% | 733,568 | - | - | 2,318,075 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.83% | 0.30% | 685,547 | 685,547 | 100.00% | 2,166,329 | Jun 30, 2024 |
| SECTORAL ASSET MANAGEMENT INC | 0.28% | 0.29% | 228,102 | 228,102 | 100.00% | 720,802 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 5.23% | 0.27% | 4,316,824 | 4,316,824 | 100.00% | 13,641,164 | Jun 30, 2024 |
| GCM GROSVENOR HOLDINGS, LLC | 0.50% | 0.19% | 410,888 | - | - | 1,298,406 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.58% | 0.17% | 474,744 | 474,744 | 100.00% | 1,500,191 | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1.57% | 0.17% | 1,296,153 | 1,296,153 | 100.00% | 4,095,843 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.25% | 0.15% | 204,081 | 204,081 | 100.00% | 644,896 | Jun 30, 2024 |
| ATOM INVESTORS LP | 0.39% | 0.10% | 322,289 | 322,289 | 100.00% | 1,018,433 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.23% | 0.08% | 1,018,461 | 1,018,461 | 100.00% | 3,218,337 | Jun 30, 2024 |
| SAXONY CAPITAL MANAGEMENT, LLC | 0.03% | 0.08% | 22,238 | 1,615 | 7.83% | 70,272 | Jun 30, 2024 |
| DLK INVESTMENT MANAGEMENT, LLC | 0.04% | 0.04% | 33,155 | - | - | 104,770 | Jun 30, 2024 |
| AVISO WEALTH MANAGEMENT | 0.01% | 0.02% | 10,343 | -125 | -1.19% | 32,684 | Jun 30, 2024 |
| PALUMBO WEALTH MANAGEMENT LLC | 0.02% | 0.02% | 13,270 | 13,270 | 100.00% | 41,934 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.07% | 0.02% | 56,863 | 32,034 | 129.02% | 179,687 | Jun 30, 2024 |
| SANIBEL CAPTIVA TRUST COMPANY, INC. | 0.14% | 0.01% | 113,000 | 10,000 | 9.71% | 357,080 | Jun 30, 2024 |
The largest ADC Therapeutics SA shareholder by % of total assets is PROSIGHT MANAGEMENT, LP. The company owns 9.57M shares of ADC Therapeutics SA (ADCT), representing 9.04% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 5.23% | 0.27% | 4,316,824 | 4,316,824 | 100.00% | 13,641,164 | Jun 30, 2024 |
| BLACKROCK INC. | 4.31% | 0.00% | 3,554,742 | 3,554,742 | 100.00% | 11,232,984 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 11.59% | 9.04% | 9,570,000 | 2,519,700 | 35.74% | 30,241,200 | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1.57% | 0.17% | 1,296,153 | 1,296,153 | 100.00% | 4,095,843 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.14% | 1.32% | 1,768,770 | 1,267,548 | 252.89% | 5,589,313 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.23% | 0.08% | 1,018,461 | 1,018,461 | 100.00% | 3,218,337 | Jun 30, 2024 |
| STATE STREET CORP | 1.20% | 0.00% | 991,296 | 991,296 | 100.00% | 3,132,495,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.00% | 0.00% | 824,717 | 824,717 | 100.00% | 2,606,104 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.83% | 0.30% | 685,547 | 685,547 | 100.00% | 2,166,329 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.58% | 0.17% | 474,744 | 474,744 | 100.00% | 1,500,191 | Jun 30, 2024 |
| VANGUARD GROUP INC | 0.49% | - | 404,229 | 404,229 | 100.00% | 1,277,364 | Jun 30, 2024 |
| ATOM INVESTORS LP | 0.39% | 0.10% | 322,289 | 322,289 | 100.00% | 1,018,433 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.40% | 0.00% | 328,764 | 273,851 | 498.70% | 1,038,894 | Jun 30, 2024 |
| MORGAN STANLEY | 3.59% | 0.00% | 2,965,229 | 244,834 | 9.00% | 9,370,123 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.29% | 0.00% | 237,304 | 237,304 | 100.00% | 749,881 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.32% | 0.00% | 263,712 | 236,791 | 879.58% | 833,330 | Jun 30, 2024 |
| SECTORAL ASSET MANAGEMENT INC | 0.28% | 0.29% | 228,102 | 228,102 | 100.00% | 720,802 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.25% | 0.00% | 205,221 | 205,221 | 100.00% | 648,498 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.25% | 0.15% | 204,081 | 204,081 | 100.00% | 644,896 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.21% | 0.00% | 175,462 | 175,462 | 100.00% | 554,460 | Jun 30, 2024 |
As of Jun 30 2024, ADC Therapeutics SA's largest institutional buyer is ORBIMED ADVISORS LLC. The company purchased 4.32M stocks of ADCT, valued at $13.64M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -1,000,000 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -500,000 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -243,243 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.99% | 0.00% | 816,456 | -193,981 | -19.20% | 2,580,001 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -120,775 | -100.00% | - | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | - | - | - | -70,636 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -23,765 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.85% | 0.00% | 1,524,717 | -15,792 | -1.03% | 4,818,106 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.00% | - | 1,938 | -12,817 | -86.87% | 6,000 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -4,787 | -100.00% | - | Jun 30, 2024 |
| AVISO WEALTH MANAGEMENT | 0.01% | 0.02% | 10,343 | -125 | -1.19% | 32,684 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 18.50% | 2.92% | 15,269,217 | - | - | 48,250,726 | Jun 30, 2024 |
| VANTAGE CONSULTING GROUP INC | 1.03% | 2.00% | 850,737 | - | - | 2,688,328 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 0.89% | 0.64% | 733,568 | - | - | 2,318,075 | Jun 30, 2024 |
| GCM GROSVENOR HOLDINGS, LLC | 0.50% | 0.19% | 410,888 | - | - | 1,298,406 | Jun 30, 2024 |
| DLK INVESTMENT MANAGEMENT, LLC | 0.04% | 0.04% | 33,155 | - | - | 104,770 | Jun 30, 2024 |
| MIRACLE MILE ADVISORS, LLC | 0.10% | 0.01% | 84,496 | - | - | 267,007 | Jun 30, 2024 |
| MAGNETAR FINANCIAL LLC | 0.07% | 0.00% | 55,762 | - | - | 176,208 | Jun 30, 2024 |
| EAGLE BAY ADVISORS LLC | 0.00% | 0.00% | 670 | - | - | 2,117 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 250 | - | - | 790 | Jun 30, 2024 |
As of Jun 30 2024, ADC Therapeutics SA's biggest institutional seller is ADAGE CAPITAL PARTNERS GP, L.L.C.. The company sold -1.00M shares of ADCT, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 5.23% | 0.27% | 4,316,824 | 4,316,824 | 100.00% | 13,641,164 | Jun 30, 2024 |
| BLACKROCK INC. | 4.31% | 0.00% | 3,554,742 | 3,554,742 | 100.00% | 11,232,984 | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1.57% | 0.17% | 1,296,153 | 1,296,153 | 100.00% | 4,095,843 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.23% | 0.08% | 1,018,461 | 1,018,461 | 100.00% | 3,218,337 | Jun 30, 2024 |
| STATE STREET CORP | 1.20% | 0.00% | 991,296 | 991,296 | 100.00% | 3,132,495,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.00% | 0.00% | 824,717 | 824,717 | 100.00% | 2,606,104 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.83% | 0.30% | 685,547 | 685,547 | 100.00% | 2,166,329 | Jun 30, 2024 |
| VANGUARD GROUP INC | 0.49% | - | 404,229 | 404,229 | 100.00% | 1,277,364 | Jun 30, 2024 |
| ATOM INVESTORS LP | 0.39% | 0.10% | 322,289 | 322,289 | 100.00% | 1,018,433 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.29% | 0.00% | 237,304 | 237,304 | 100.00% | 749,881 | Jun 30, 2024 |
| SECTORAL ASSET MANAGEMENT INC | 0.28% | 0.29% | 228,102 | 228,102 | 100.00% | 720,802 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.25% | 0.00% | 205,221 | 205,221 | 100.00% | 648,498 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.25% | 0.15% | 204,081 | 204,081 | 100.00% | 644,896 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.21% | 0.00% | 175,462 | 175,462 | 100.00% | 554,460 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.12% | 0.00% | 100,000 | 100,000 | 100.00% | 316,000 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.10% | 0.00% | 85,977 | 85,977 | 100.00% | 271,677 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.05% | 0.00% | 39,750 | 39,750 | 100.00% | 125,610 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 37,666 | 37,666 | 100.00% | 119,401 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.04% | 0.00% | 35,600 | 35,600 | 100.00% | 112,000 | Jun 30, 2024 |
| BARCLAYS PLC | 0.04% | - | 33,849 | 33,849 | 100.00% | 107,000 | Jun 30, 2024 |
| INVESCO LTD. | 0.04% | - | 32,959 | 32,959 | 100.00% | 104,150 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.04% | - | 29,837 | 29,837 | 100.00% | 94,285 | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.03% | 0.00% | 26,938 | 26,938 | 100.00% | 85,124 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.03% | - | 25,704 | 25,704 | 100.00% | 81,225 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.03% | 0.00% | 24,120 | 24,120 | 100.00% | 76,219 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.03% | - | 23,014 | 23,014 | 100.00% | 72,724,000 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.03% | - | 22,020 | 22,020 | 100.00% | 69,583 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.02% | 0.00% | 18,810 | 18,810 | 100.00% | 59,440 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.02% | 0.00% | 15,925 | 15,925 | 100.00% | 50,323 | Jun 30, 2024 |
| PALUMBO WEALTH MANAGEMENT LLC | 0.02% | 0.02% | 13,270 | 13,270 | 100.00% | 41,934 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.01% | 0.00% | 10,355 | 10,355 | 100.00% | 32,722 | Jun 30, 2024 |
| NOMURA HOLDINGS INC | 0.01% | 0.00% | 10,000 | 10,000 | 100.00% | 31,600 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 7,085 | 7,085 | 100.00% | 22,282 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 6,859 | 6,859 | 100.00% | 21,674 | Jun 30, 2024 |
| STATE OF WYOMING | 0.01% | 0.00% | 6,221 | 6,221 | 100.00% | 19,658 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.01% | - | 5,073 | 5,073 | 100.00% | 16,031 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | 0.00% | 2,422 | 2,422 | 100.00% | 8,000 | Jun 30, 2024 |
| GLOBAL RETIREMENT PARTNERS, LLC | 0.00% | - | 200 | 200 | 100.00% | 632 | Jun 30, 2024 |
| HARBOUR INVESTMENTS, INC. | - | - | 20 | 20 | 100.00% | 63 | Jun 30, 2024 |
| GRADIENT INVESTMENTS LLC | - | - | 11 | 11 | 100.00% | 35 | Jun 30, 2024 |
ADC Therapeutics SA's largest new institutional shareholder by number of shares is ORBIMED ADVISORS LLC, purchased 4.32M shares, valued at $13.64M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -1,000,000 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -500,000 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -243,243 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -120,775 | -100.00% | - | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | - | - | - | -70,636 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -23,765 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -4,787 | -100.00% | - | Jun 30, 2024 |
ADC Therapeutics SA's largest sold out institutional shareholder by shares sold is ADAGE CAPITAL PARTNERS GP, L.L.C., sold -1.00M shares, valued at -, as of undefined.
ADC Therapeutics SA Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.04% | 407,550 | - | - | Jan 31, 2024 |
| ALGER FUNDS | 0.04% | 35,000 | - | - | Jan 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.00% | 130,337 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 44,710 | - | - | Feb 29, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 20,602 | - | - | Mar 31, 2024 |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0.00% | 40,200 | - | - | Mar 31, 2024 |
| MASSMUTUAL PREMIER FUNDS | 0.00% | 25,708 | - | - | Dec 31, 2023 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 7,509 | - | - | Jan 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 1,068,468 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 15,432 | - | - | Jan 31, 2024 |
| MML Series Investment Fund II | 0.00% | 10,488 | - | - | Dec 31, 2023 |
| PRINCIPAL FUNDS, INC. | 0.00% | 274,400 | - | - | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 1,091 | - | - | Mar 31, 2024 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 60,321 | - | - | Mar 31, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 87,562 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 23,188 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 1,447 | - | - | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,797 | - | - | Dec 31, 2023 |
| AIM INVESTMENT FUNDS (INVESCO INVESTMENT FUNDS) | 0.00% | 21,603 | - | - | Jan 31, 2024 |
ADC Therapeutics SA's largest mutual fund holder by % of total assets is "AMERICAN CENTURY MUTUAL FUNDS, INC.", owning 407.55K shares, compromising 0.04% of its total assets.
ADC Therapeutics SA Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 71 | 77.50% |
| 31 Mar, 24 | 40 | 11.11% |
| 31 Dec, 23 | 36 | -14.29% |
| 30 Sep, 23 | 42 | -27.59% |
| 30 Jun, 23 | 58 | - |
| 31 Mar, 23 | 58 | -6.45% |
| 31 Dec, 22 | 62 | -1.59% |
| 30 Sep, 22 | 63 | 8.62% |
| 30 Jun, 22 | 58 | 20.83% |
| 31 Mar, 22 | 48 | -12.73% |
| 31 Dec, 21 | 55 | 3.77% |
| 30 Sep, 21 | 53 | -10.17% |
| 30 Jun, 21 | 59 | -3.28% |
| 31 Mar, 21 | 61 | 17.31% |
| 31 Dec, 20 | 52 | - |
| 30 Sep, 20 | 52 | 30.00% |
| 30 Jun, 20 | 40 | - |
As of 30 Jun 24, 71 institutions are holding ADC Therapeutics SA's shares, representing an increase of 77.50% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 50,979,292 | 46.98% |
| 31 Mar, 24 | 34,683,534 | 2.21% |
| 31 Dec, 23 | 33,934,768 | -14.00% |
| 30 Sep, 23 | 39,460,029 | -13.00% |
| 30 Jun, 23 | 45,358,190 | -2.67% |
| 31 Mar, 23 | 46,601,042 | 20.00% |
| 31 Dec, 22 | 38,834,711 | 6.04% |
| 30 Sep, 22 | 36,621,885 | 6.12% |
| 30 Jun, 22 | 34,510,976 | 1.22% |
| 31 Mar, 22 | 34,095,342 | 0.97% |
| 31 Dec, 21 | 33,767,606 | 3.11% |
| 30 Sep, 21 | 32,749,359 | -2.21% |
| 30 Jun, 21 | 33,490,113 | 2.02% |
| 31 Mar, 21 | 32,826,186 | 3.64% |
| 31 Dec, 20 | 31,672,736 | 12.34% |
| 30 Sep, 20 | 28,194,098 | 30.94% |
| 30 Jun, 20 | 21,531,745 | - |
ADC Therapeutics SA (ADCT) has 50.98M shares outstanding as of 30 Jun 24, up 46.98% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 61.75% | 3.43% |
| 31 Mar, 24 | 42.45% | 2.49% |
| 31 Dec, 23 | 41.25% | 1.76% |
| 30 Sep, 23 | 48.43% | 1.54% |
| 30 Jun, 23 | 56.13% | 1.69% |
| 31 Mar, 23 | 57.67% | 1.64% |
| 31 Dec, 22 | 59.37% | 2.72% |
| 30 Sep, 22 | 46.73% | 2.32% |
| 30 Jun, 22 | 44.87% | 2.28% |
| 31 Mar, 22 | 44.38% | 2.27% |
| 31 Dec, 21 | 44.20% | 2.43% |
| 30 Sep, 21 | 42.68% | 2.24% |
| 30 Jun, 21 | 43.65% | 2.38% |
| 31 Mar, 21 | 42.79% | 1.82% |
| 31 Dec, 20 | 48.42% | 3.06% |
| 30 Sep, 20 | 39.76% | 3.39% |
| 30 Jun, 20 | 34.25% | - |
As of 30 Jun 24, ADC Therapeutics SA is held by 61.75% institutional shareholders, representing a 3.43% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 55 | 161.90% |
| 31 Mar, 24 | 21 | 61.54% |
| 31 Dec, 23 | 13 | -23.53% |
| 30 Sep, 23 | 17 | -29.17% |
| 30 Jun, 23 | 24 | -35.14% |
| 31 Mar, 23 | 37 | 8.82% |
| 31 Dec, 22 | 34 | 21.43% |
| 30 Sep, 22 | 28 | -15.15% |
| 30 Jun, 22 | 33 | 65.00% |
| 31 Mar, 22 | 20 | -23.08% |
| 31 Dec, 21 | 26 | 18.18% |
| 30 Sep, 21 | 22 | -26.67% |
| 30 Jun, 21 | 30 | -14.29% |
| 31 Mar, 21 | 35 | 20.69% |
| 31 Dec, 20 | 29 | -23.68% |
| 30 Sep, 20 | 38 | -5.00% |
| 30 Jun, 20 | 40 | - |
55 institutional shareholders have increased their position in ADCT stock as of 30 Jun 24 compared to 21 in the previous quarter (a 161.90% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 4 | -50.00% |
| 31 Mar, 24 | 8 | -20.00% |
| 31 Dec, 23 | 10 | -23.08% |
| 30 Sep, 23 | 13 | -23.53% |
| 30 Jun, 23 | 17 | 88.89% |
| 31 Mar, 23 | 9 | -40.00% |
| 31 Dec, 22 | 15 | -28.57% |
| 30 Sep, 22 | 21 | 133.33% |
| 30 Jun, 22 | 9 | -25.00% |
| 31 Mar, 22 | 12 | -14.29% |
| 31 Dec, 21 | 14 | -26.32% |
| 30 Sep, 21 | 19 | 90.00% |
| 30 Jun, 21 | 10 | -16.67% |
| 31 Mar, 21 | 12 | - |
| 31 Dec, 20 | 12 | 71.43% |
| 30 Sep, 20 | 7 | - |
| 30 Jun, 20 | - | - |
4 institutional shareholders have reduced their position in ADCT stock as of 30 Jun 24 compared to 8 in the previous quarter (a -50.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 71 | 77.50% | 50,979,292 | 46.98% | 61.75% | 3.43% | 55 | 161.90% | 4 | -50.00% |
| 31 Mar, 24 | 40 | 11.11% | 34,683,534 | 2.21% | 42.45% | 2.49% | 21 | 61.54% | 8 | -20.00% |
| 31 Dec, 23 | 36 | -14.29% | 33,934,768 | -14.00% | 41.25% | 1.76% | 13 | -23.53% | 10 | -23.08% |
| 30 Sep, 23 | 42 | -27.59% | 39,460,029 | -13.00% | 48.43% | 1.54% | 17 | -29.17% | 13 | -23.53% |
| 30 Jun, 23 | 58 | - | 45,358,190 | -2.67% | 56.13% | 1.69% | 24 | -35.14% | 17 | 88.89% |
| 31 Mar, 23 | 58 | -6.45% | 46,601,042 | 20.00% | 57.67% | 1.64% | 37 | 8.82% | 9 | -40.00% |
| 31 Dec, 22 | 62 | -1.59% | 38,834,711 | 6.04% | 59.37% | 2.72% | 34 | 21.43% | 15 | -28.57% |
| 30 Sep, 22 | 63 | 8.62% | 36,621,885 | 6.12% | 46.73% | 2.32% | 28 | -15.15% | 21 | 133.33% |
| 30 Jun, 22 | 58 | 20.83% | 34,510,976 | 1.22% | 44.87% | 2.28% | 33 | 65.00% | 9 | -25.00% |
| 31 Mar, 22 | 48 | -12.73% | 34,095,342 | 0.97% | 44.38% | 2.27% | 20 | -23.08% | 12 | -14.29% |
| 31 Dec, 21 | 55 | 3.77% | 33,767,606 | 3.11% | 44.20% | 2.43% | 26 | 18.18% | 14 | -26.32% |
| 30 Sep, 21 | 53 | -10.17% | 32,749,359 | -2.21% | 42.68% | 2.24% | 22 | -26.67% | 19 | 90.00% |
| 30 Jun, 21 | 59 | -3.28% | 33,490,113 | 2.02% | 43.65% | 2.38% | 30 | -14.29% | 10 | -16.67% |
| 31 Mar, 21 | 61 | 17.31% | 32,826,186 | 3.64% | 42.79% | 1.82% | 35 | 20.69% | 12 | - |
| 31 Dec, 20 | 52 | - | 31,672,736 | 12.34% | 48.42% | 3.06% | 29 | -23.68% | 12 | 71.43% |
| 30 Sep, 20 | 52 | 30.00% | 28,194,098 | 30.94% | 39.76% | 3.39% | 38 | -5.00% | 7 | - |
| 30 Jun, 20 | 40 | - | 21,531,745 | - | 34.25% | - | 40 | - | - | - |
ADC Therapeutics SA Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of ADC Therapeutics SA's stock was made by Azelby Robert on Jun 18 2024, selling 6,995 shares at $2.89 per share (valued at $20.22K). The last insider buy of ADCT was made by Redmile Group, LLC on Jul 03 2024, buying 400,000 shares at $2.81 per share (worth $1.12M).
ADC Therapeutics SA Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | - | - |
| Q2 2024 | 9 | 8 | 112.50% |
| Q1 2024 | 20 | 41 | 48.78% |
| Q4 2010 | - | 44 | - |
| Q1 2010 | 6 | 2 | 300.00% |
| Q4 2009 | 5 | 2 | 250.00% |
| Q3 2009 | 1 | 2 | 50.00% |
| Q1 2009 | 7 | 3 | 233.33% |
| Q4 2008 | 7 | 3 | 233.33% |
| Q1 2008 | 8 | - | - |
| Q4 2007 | 4 | 2 | 200.00% |
| Q2 2007 | - | 3 | - |
| Q1 2007 | 13 | 2 | 650.00% |
| Q4 2006 | 10 | 5 | 200.00% |
| Q3 2006 | - | 1 | - |
| Q2 2006 | 7 | - | - |
| Q1 2006 | 13 | 2 | 650.00% |
| Q4 2005 | 8 | 6 | 133.33% |
| Q3 2005 | - | 1 | - |
| Q1 2005 | 16 | 2 | 800.00% |
2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by ADC Therapeutics SA's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | - | - |
| Q2 2024 | 2 | 8 | 25.00% |
| Q1 2024 | 20 | - | - |
| Q4 2010 | - | - | - |
| Q1 2010 | - | - | - |
| Q4 2009 | - | - | - |
| Q3 2009 | - | - | - |
| Q1 2009 | 1 | - | - |
| Q4 2008 | 2 | - | - |
| Q1 2008 | - | - | - |
| Q4 2007 | - | - | - |
| Q2 2007 | - | 1 | - |
| Q1 2007 | - | - | - |
| Q4 2006 | - | - | - |
| Q3 2006 | - | - | - |
| Q2 2006 | 6 | - | - |
| Q1 2006 | - | - | - |
| Q4 2005 | - | - | - |
| Q3 2005 | - | - | - |
| Q1 2005 | - | - | - |
As of Q3 2024, Insider owners conducted 2 open market buy trades and 0 open market sell trades of ADC Therapeutics SA's stocks.
ADC Therapeutics SA Peer Ownership
| Ticker | Company |
|---|---|
| AKRO | Akero Therapeutics, Inc. |
| ARVN | Arvinas, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| STOK | Stoke Therapeutics, Inc. |
| IPSC | Century Therapeutics, Inc. |
| ALEC | Alector, Inc. |
| RNA | Avidity Biosciences, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| GBIO | Generation Bio Co. |
| ALXO | ALX Oncology Holdings Inc. |
| PASG | Passage Bio, Inc. |
| ALVR | AlloVir, Inc. |
| CRNX | Crinetics Pharmaceuticals, Inc. |
| DSGN | Design Therapeutics, Inc. |
| PTGX | Protagonist Therapeutics, Inc. |
| KURA | Kura Oncology, Inc. |
| FIXX | Q32 Bio Inc. |
| RARE | Ultragenyx Pharmaceutical Inc. |
| AADI | Aadi Bioscience, Inc. |
ADCT Ownership FAQ
Who Owns ADC Therapeutics SA?
ADC Therapeutics SA is owned by institutional shareholders (61.75%), insiders (20.96%), and public (17.29%). The largest institutional shareholder of ADC Therapeutics SA is REDMILE GROUP, LLC (18.50% of total shares) and the top mutual fund owner is AMERICAN CENTURY MUTUAL FUNDS, INC. (0.04% of total shares).
Who are the major institutional shareholders of ADC Therapeutics SA?
ADC Therapeutics SA's major institutional shareholders are REDMILE GROUP, LLC, PROSIGHT MANAGEMENT, LP, ORBIMED ADVISORS LLC, BLACKROCK INC., and MORGAN STANLEY. The top five shareholders own together 43.22% of the company's share outstanding.
How many ADC Therapeutics SA shareholders are there?
As of Jun 2024, there are 71 institutional shareholders of ADC Therapeutics SA.
What percentage of ADC Therapeutics SA is owned by REDMILE GROUP, LLC?
REDMILE GROUP, LLC owns 15.27M shares of ADC Therapeutics SA, representing 18.50% of the company's total shares outstanding, valued at $48.25M (as of Jun 2024).
What percentage of ADC Therapeutics SA is owned by PROSIGHT MANAGEMENT, LP?
As of Jun 2024, PROSIGHT MANAGEMENT, LP holds 9.57M shares of ADC Therapeutics SA (ADCT), compromising 11.59% of the company, valued at $30.24M.
What percentage of ADC Therapeutics SA is owned by ORBIMED ADVISORS LLC?
ORBIMED ADVISORS LLC is the third largest holder of ADC Therapeutics SA. The company owns 4.32M of the company's shares outstanding (worth $13.64M).